Europe Multiplex Assay Market Forecast 2021-2028

KEY FINDINGS

The Europe multiplex assay market is evaluated to register a CAGR of 8.37% during the estimated period of 2021 to 2028. Factors such as the increase in healthcare expenditure, the growing focus of the European government towards technological advancements in medical devices, the rapidly rising geriatric population, and the well-established presence of healthcare systems predominantly propel the region's market growth.

MARKET INSIGHTS

The Europe multiplex assay market growth assessment constitutes the study of Russia, Belgium, the United Kingdom, Italy, France, Poland, Germany, and the rest of Europe. As per the data issued by the Association of the British Pharmaceutical Industry, pharmaceuticals constitute the highest research and development expenditure sector in the country. The COVID-19 outbreak has encouraged the United Kingdom's pharmaceutical industry to develop numerous therapeutic interventions, as well. Hence, the vigorous research and development activities undertaken in the country are anticipated to increase the demand for multiplex assays.

On the other hand, according to the World Bank Group, 1.35% of the total gross domestic product (GDP) in 2017 was spent on research and development spending. As one of the most significant economies across Europe, Italy is anticipated to raise its expenditure on research and development, in addition to the adoption of numerous devices, thereby fueling the demand for multiplex assay. Furthermore, with the increase in healthcare expenditure, the access to healthcare and diagnoses increases, with a subsequent rise in the need for diagnostics. Therefore, these factors are set to play a vital role in augmenting the market growth in Europe during the forecasted years.

COMPETITIVE INSIGHTS

Some of the top companies operating in the market are: F. Hoffmann-La Roche, Siemens Healthineers AG, Agilent Technologies Inc, etc.

Our report offerings include:

• Explore key findings of the overall market

• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

• Market Segmentation cater to a thorough assessment of key segments with their market estimations

• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

• 1.1. STUDY OBJECTIVES
• 1.2. SCOPE OF STUDY
• 1.3. METHODOLOGY
• 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

• 2.1. MARKET SIZE & ESTIMATES
• 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

• 3.1. KEY DRIVERS
  • 3.1.1. PREFERENCE OF MULTIPLEX ASSAYS OVER CONVENTIONAL ASSAYS
  • 3.1.2. ADOPTION OF PERSONALIZED MEDICINES
• 3.2. KEY RESTRAINTS
  • 3.2.1. UNAVAILABILITY OF SKILLED LAB TECHNICIANS
  • 3.2.2. COMPLIANCE WITH STRICT ENVIRONMENTAL REGULATION

4. KEY ANALYTICS

• 4.1. IMPACT OF COVID-19 ON MULTIPLEX ASSAY MARKET
• 4.2. KEY MARKET TRENDS
• 4.3. PORTER'S FIVE FORCES ANALYSIS
  • 4.3.1. BUYERS POWER
  • 4.3.2. SUPPLIERS POWER
  • 4.3.3. SUBSTITUTION
  • 4.3.4. NEW ENTRY
  • 4.3.5. INDUSTRY RIVALRY
• 4.4. KEY BUYING CRITERIA
• 4.5. OPPORTUNITY MATRIX
• 4.6. VENDOR LANDSCAPE

5. MARKET BY TYPE

• 5.1. PROTEIN-BASED MULTIPLEX ASSAY
• 5.2. NUCLEIC ACID-BASED MULTIPLEX ASSAY
• 5.3. OTHER MULTIPLEX ASSAYS

6. MARKET BY PRODUCT

• 6.1. REAGENTS AND CONSUMABLES
• 6.2. INSTRUMENTS AND ACCESSORIES
• 6.3. SOFTWARE AND SERVICES

7. MARKET BY TECHNOLOGY

• 7.1. MULTIPLEX PROTEIN MICROARRAY
• 7.2. MULTIPLEX PCR
• 7.3. OTHER TECHNOLOGIES

8. MARKET BY APPLICATION

• 8.1. CLINICAL DIAGNOSTICS
• 8.2. RESEARCH AND DEVELOPMENT
• 8.3. COMPANION DIAGNOSTICS

9. MARKET BY END-USER

• 9.1. HOSPITALS
• 9.2. CLINICAL LABORATORIES
• 9.3. RESEARCH INSTITUTES
• 9.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10. GEOGRAPHICAL ANALYSIS

• 10.1. EUROPE
  • 10.1.1. MARKET SIZE & ESTIMATES
  • 10.1.2. KEY GROWTH ENABLERS
  • 10.1.3. KEY CHALLENGES
  • 10.1.4. KEY PLAYERS
  • 10.1.5. COUNTRY ANALYSIS
    • 10.1.5.1. GERMANY
    • 10.1.5.2. FRANCE
    • 10.1.5.3. UNITED KINGDOM
    • 10.1.5.4. ITALY
    • 10.1.5.5. RUSSIA
    • 10.1.5.6. BELGIUM
    • 10.1.5.7. POLAND
    • 10.1.5.8. REST OF EUROPE

11. COMPETITIVE LANDSCAPE

• 11.1. KEY STRATEGIC DEVELOPMENTS
  • 11.1.1. MERGERS & ACQUISITIONS
  • 11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
  • 11.1.3. PARTNERSHIPS & AGREEMENTS
  • 11.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
• 11.2. COMPANY PROFILES
  • 11.2.1. ABCAM
  • 11.2.2. AGILENT TECHNOLOGIES INC
  • 11.2.3. BECTON, DICKINSON AND COMPANY (BD)
  • 11.2.4. BIO-RAD LABORATORIES INC
  • 11.2.5. BIO-TECHNE CORPORATION
  • 11.2.6. F. HOFFMANN-LA ROCHE
  • 11.2.7. ILLUMINA INC
  • 11.2.8. LUMINEX CORPORATION
  • 11.2.9. MERCK MILLIPORE
  • 11.2.10. OLINK PROTEOMICS AB
  • 11.2.11. QIAGEN NV
  • 11.2.12. RANDOX LABORATORIES LTD
  • 11.2.13. SEEGENE INC
  • 11.2.14. SIEMENS HEALTHINEERS AG
  • 11.2.15. THERMO FISHER SCIENTIFIC INC

LIST OF TABLES

• TABLE 1: MARKET SNAPSHOT - MULTIPLEX ASSAY
• TABLE 2: EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 3: EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 4: EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 5: EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 6: EUROPE MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 7: EUROPE MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 8: EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 9: EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 10: EUROPE MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 11: EUROPE MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 12: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 13: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 14: LEADING PLAYERS OPERATING IN THE EUROPE MULTIPLEX ASSAY MARKET
• TABLE 15: LIST OF MERGERS & ACQUISITIONS
• TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
• TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS
• TABLE 18: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES

• FIGURE 1: KEY MARKET TRENDS
• FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 3: OPPORTUNITY MATRIX
• FIGURE 4: VENDOR LANDSCAPE
• FIGURE 5: EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, IN 2020
• FIGURE 6: EUROPE MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
• FIGURE 7: EUROPE MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
• FIGURE 8: EUROPE MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2021-2028 (IN $ MILLION)
• FIGURE 9: EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, IN 2020
• FIGURE 10: EUROPE MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2021-2028 (IN $ MILLION)
• FIGURE 11: EUROPE MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2021-2028 (IN $ MILLION)
• FIGURE 12: EUROPE MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2021-2028 (IN $ MILLION)
• FIGURE 13: EUROPE MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, IN 2020
• FIGURE 14: EUROPE MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2021-2028 (IN $ MILLION)
• FIGURE 15: EUROPE MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2021-2028 (IN $ MILLION)
• FIGURE 16: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)
• FIGURE 17: EUROPE MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
• FIGURE 18: EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, IN 2020
• FIGURE 19: EUROPE MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)
• FIGURE 20: EUROPE MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
• FIGURE 21: EUROPE MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
• FIGURE 22: EUROPE MULTIPLEX ASSAY MARKET, BY END-USER, IN 2020
• FIGURE 23: EUROPE MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
• FIGURE 24: EUROPE MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2021-2028 (IN $ MILLION)
• FIGURE 25: EUROPE MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
• FIGURE 26: EUROPE MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
• FIGURE 27: EUROPE MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
• FIGURE 28: GERMANY MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 29: FRANCE MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 30: UNITED KINGDOM MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 31: ITALY MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 32: RUSSIA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 33: BELGIUM MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 34: POLAND MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 35: REST OF EUROPE MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)